Literature DB >> 19252785

Vestibular migraine: a critical review of treatment trials.

Majid Fotuhi1, Braeme Glaun, Susan Y Quan, Tzipora Sofare.   

Abstract

Vestibular migraine (VM), also known as migraine-associated vertigo, is a common cause of dizziness in adults. We performed a comprehensive literature search regarding treatment for VM or migraine-associated vertigo during the period of 1990-2008 and used, individually or in combination, the search terms VM, migraine-associated vertigo, migraine-associated dizziness, migrainous vertigo, migraine and vertigo, migraine and disequilibrium, and headache and vertigo. We found nine publications that address treatment strategies for VM. One small randomized clinical trial found some benefit from the use of zolmitriptan for abortive treatment of VM. The other eight observational studies showed marginal improvement with migraine prophylactic medications such as nortriptyline, verapamil, or metoprolol. Until more specific treatment options become available, patients with VM need to be managed with similar prophylactic and abortive strategies as those used for migraine in adults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252785     DOI: 10.1007/s00415-009-5050-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Episodic vertigo related to migraine (90 cases): vestibular migraine?

Authors:  M Dieterich; T Brandt
Journal:  J Neurol       Date:  1999-10       Impact factor: 4.849

2.  Migraine-associated vertigo.

Authors:  P A Savundra; J D Carroll; R A Davies; L M Luxon
Journal:  Cephalalgia       Date:  1997-06       Impact factor: 6.292

3.  Migraine-associated dizziness: patient characteristics and management options.

Authors:  Mark D Reploeg; Joel A Goebel
Journal:  Otol Neurotol       Date:  2002-05       Impact factor: 2.311

4.  Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine.

Authors:  S L Whitney; D M Wrisley; K E Brown; J M Furman
Journal:  Laryngoscope       Date:  2000-09       Impact factor: 3.325

5.  Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms.

Authors:  Sergio Carmona; Norma Settecase
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

6.  Migraine-related vertigo: diagnostic criteria and prophylactic treatment.

Authors:  Arturo Maione
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

7.  Chronic migrainous vertigo.

Authors:  John Waterston
Journal:  J Clin Neurosci       Date:  2004-05       Impact factor: 1.961

8.  Symptoms in the community. Prevalence, classification, and psychiatric comorbidity.

Authors:  K Kroenke; R K Price
Journal:  Arch Intern Med       Date:  1993-11-08

Review 9.  Vertigo and dizziness related to migraine: a diagnostic challenge.

Authors:  H Neuhauser; T Lempert
Journal:  Cephalalgia       Date:  2004-02       Impact factor: 6.292

Review 10.  Migraine-related vertigo: diagnosis and treatment.

Authors:  Scott D Z Eggers
Journal:  Curr Pain Headache Rep       Date:  2007-06
View more
  17 in total

Review 1.  Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome.

Authors:  Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

2.  Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications.

Authors:  Carey D Balaban; Rolf G Jacob; Joseph M Furman
Journal:  Expert Rev Neurother       Date:  2011-03       Impact factor: 4.618

3.  [Vestibular migraine: diagnostic criteria: consensus document of the Bárány Society and the International Headache Society].

Authors:  T Lempert; J Olesen; J Furman; J Waterston; B Seemungal; J Carey; A Bisdorff; M Versino; S Evers; D Newman-Toker
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 4.  Vestibular Migraine.

Authors:  Gülden Akdal
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 5.  Clinical and electrographic findings in epileptic vertigo and dizziness: a systematic review.

Authors:  Alexander A Tarnutzer; Seung-Han Lee; Karen A Robinson; Peter W Kaplan; David E Newman-Toker
Journal:  Neurology       Date:  2015-03-20       Impact factor: 9.910

6.  Management of vestibular migraine.

Authors:  Alexandre R Bisdorff
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

7.  Vestibular rehabilitation outcomes in patients with and without vestibular migraine.

Authors:  Jessica Vitkovic; Arimbi Winoto; Gary Rance; Richard Dowell; Mark Paine
Journal:  J Neurol       Date:  2013-09-24       Impact factor: 4.849

8.  Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.

Authors:  Anjali Lepcha; Sophia Amalanathan; Ann Mary Augustine; Amit Kumar Tyagi; Achamma Balraj
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-29       Impact factor: 2.503

9.  New methods for diagnosis and treatment of vestibular diseases.

Authors:  Stefan Ca Hegemann; Antonella Palla
Journal:  F1000 Med Rep       Date:  2010-08-09

10.  The Relationship Between Vestibular Migraine and Motion Sickness Susceptibility.

Authors:  Mehdi Abouzari; Dillon Cheung; Tiffany Pham; Khodayar Goshtasbi; Brooke Sarna; Sarah Tajran; Sammy Sahyouni; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2020-09       Impact factor: 2.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.